Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.

Source: [CNBC](https://www.cnbc.com/2026/08/04/merck-mrk-earnings-q2-2026.html)